Blueshift Asset Management’s Emergent Biosolutions EBS Stock Holding History

Blueshift Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-37,628	Closed	-$1.64M	–	906
2021 Q4	$1.64M	Buy	+37,628	New	+$1.7M	0.14%	188
2020 Q4	–	Sell	-3,920	Closed	-$405K	–	738
2020 Q3	$405K	Buy	+3,920	New	+$423K	0.06%	386
2019 Q2	–	Sell	-23,381	Closed	-$1.18M	–	764
2019 Q1	$1.18M	Buy	+23,381	New	+$1.38M	0.17%	205

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Blueshift Asset Management's EBS Position: Q1 2022 in Review

Blueshift Asset Management sold out of Emergent Biosolutions (EBS) in Q1 2022, closing a stake of 37,628 shares — an estimated $1.64M sold.

Blueshift Asset Management first reported a position in EBS in Q1 2019 and held it in 3 quarters. The position peaked at $1.64M in Q4 2021. 255 funds tracked by Wall St. Rank hold EBS as of Q1 2022.

Blueshift Asset Management reported no remaining Emergent Biosolutions position as of Q1 2022 after selling out during the quarter.
Blueshift Asset Management sold 37,628 Emergent Biosolutions shares in Q1 2022, an estimated $1.64M.
Blueshift Asset Management first reported a position in Emergent Biosolutions in Q1 2019 and held it in 3 quarters.
Blueshift Asset Management's Emergent Biosolutions position peaked at $1.64M in Q4 2021.
255 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2022.

Based on Blueshift Asset Management's 13F filing for Q1 2022, filed 12 May 2022.